- Jun 24, 2016

ClinSpec Dx progress to phase three of Converge Challenge

ClinSpec Dx are through to the third phase of the Converge Challenge. Watch Matt Baker talk about our technology here .

Recent Posts

Dxcover to release new data on early detection liquid biopsy for multiple cancer types at 2022 ASCO

Scotland, UK., May 19, 2022 Dxcover Limited, a clinical stage diagnostics company developing its spectroscopic biopsy technology for early detection of multiple cancers, today announced that it will b

Dxcover to release data on early detection of multiple-solid tumors at AACR 2022 Annual Meeting

Data highlight high sensitivity of novel infrared spectroscopy approach for stage I disease SCOTLAND, UK., March 29, 2022 Dxcover Limited, a clinical stage diagnostics company developing its spectrosc

Dxcover advances fast-track cancer diagnosis

Cancer diagnostics company, Dxcover Limited, has published its latest data from clinical studies on earlier detection of aggressive cancers. The study[i] involving over 980 patients suffering from non